CK1α inhibition in MM was proposed to act via several mechanisms including the inhibition of the pro-survival autophagy [143,144], regulation of MYC [141] or by unleashing p53-driven apoptosis [142]. The gene discussed is TP53; the disease is Miyoshi myopathy.